Recent advances on NOTCH signaling in T-ALL
- PMID: 22673746
- DOI: 10.1007/82_2012_232
Recent advances on NOTCH signaling in T-ALL
Abstract
NOTCH1 receptor signaling plays a central role in T-cell lineage specification and in supporting the growth and proliferation of immature T-cell progenitors in the thymus during lymphoid development. In T-cell acute lymphoblastic leukemia (T-ALL), a tumor resulting from the malignant transformation of T-cell progenitors, aberrant and constitutively active NOTCH1 signaling triggered by activating mutations in the NOTCH1 gene contributes to oncogenic transformation and is a hallmark of this disease. Most notably, small molecule γ-secretase inhibitors (GSIs) can effectively block NOTCH1 signaling in T-ALL, and could be exploited as a targeted therapy in this disease. In addition, a number of emerging anti-NOTCH therapeutic strategies including anti-NOTCH1 inhibitory antibodies, small peptide inhibitors of NOTCH signaling and combination therapies with GSIs and glucocorticoids, have recently been proposed. Finally, the identification of NOTCH1 mutations in solid tumors and chronic lymphocytic leukemias has increased even further the clinical relevance of NOTCH signaling as a therapeutic target in human cancer. Here we review our current understanding of NOTCH1-induced transformation, the mechanisms of action of oncogenic NOTCH1 in T-ALL and the therapeutic and prognostic implications of NOTCH1 mutations in T-ALL.
Similar articles
-
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.Haematologica. 2014 Dec;99(12):1808-16. doi: 10.3324/haematol.2014.115683. Epub 2014 Oct 24. Haematologica. 2014. PMID: 25344525 Free PMC article.
-
The role of NOTCH1 signaling in T-ALL.Hematology Am Soc Hematol Educ Program. 2009:353-61. doi: 10.1182/asheducation-2009.1.353. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008221 Free PMC article. Review.
-
New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.Cell Signal. 2014 Jan;26(1):149-61. doi: 10.1016/j.cellsig.2013.09.021. Epub 2013 Oct 16. Cell Signal. 2014. PMID: 24140475 Review.
-
Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.Cancer Res. 2009 Apr 1;69(7):3060-8. doi: 10.1158/0008-5472.CAN-08-4295. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318552
-
The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.Haematologica. 2016 Sep;101(9):1010-7. doi: 10.3324/haematol.2016.146381. Haematologica. 2016. PMID: 27582570 Free PMC article. Review.
Cited by
-
Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia.Front Pediatr. 2022 Jun 6;10:831229. doi: 10.3389/fped.2022.831229. eCollection 2022. Front Pediatr. 2022. PMID: 35733807 Free PMC article.
-
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4. PLoS One. 2013. PMID: 23308108 Free PMC article.
-
Par-4/THAP1 complex and Notch3 competitively regulated pre-mRNA splicing of CCAR1 and affected inversely the survival of T-cell acute lymphoblastic leukemia cells.Oncogene. 2013 Dec 12;32(50):5602-13. doi: 10.1038/onc.2013.349. Epub 2013 Aug 26. Oncogene. 2013. PMID: 23975424 Free PMC article.
-
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.Nat Med. 2014 Oct;20(10):1130-7. doi: 10.1038/nm.3665. Epub 2014 Sep 7. Nat Med. 2014. PMID: 25194570 Free PMC article.
-
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.Mol Oncol. 2021 May;15(5):1412-1431. doi: 10.1002/1878-0261.12877. Epub 2021 Feb 13. Mol Oncol. 2021. PMID: 33314742 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources